Cargando…
A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment
BACKGROUND: Haematotoxicity of conventional chemotherapies often results in delays of treatment or reduction of chemotherapy dose. To ameliorate these side-effects, patients are routinely treated with blood transfusions or haematopoietic growth factors such as erythropoietin (EPO) or granulocyte col...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046020/ https://www.ncbi.nlm.nih.gov/pubmed/24886056 http://dx.doi.org/10.1186/1742-4682-11-24 |